FDA Updates Sanofi's FLUBLOK Vaccine Label With New Safety Data For Pregnant Individuals
Sanofi (SNYNF, SNY) said that the U.S. Food and Drug Administration has updated the label for FLUBLOK (Influenza Vaccine) to include ...
The Pharma Letter1d
Sanofi’s US Flublok label updated
The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza ...
FierceBiotech2d
FDA puts Novavax's phase 3 plan for pair of vaccine programs on hold over nerve disease case
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...
FLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals
The U.S. Food and Drug Administration (FDA) has updated the label for FLUBLOK (Influenza Vaccine) to include data from a new safety study involving pregnant individuals 18 years and older, in time to ...
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare ...
FierceBiotech1d
With trial win, Merck's RSV antibody clesrovimab looks poised to take on Sanofi and AZ's Beyfortus
Clesrovimab scored on several endpoints, showing an ability to protect infants against the virus in their first RSV season.
devdiscourse4d
WHO Approves Vaccine for Adolescents Amid Global Health Developments
Recent health news highlights include WHO's approval of an mpox vaccine for adolescents, $1 billion in WHO budget pledges, ...
PharmiWeb3d
Sanofi launches high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK
Sanofi launches high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK ·       Developed with a higher antigen content to increase protection in older adults, a population at greater ...